PDA 2024 - WW Conference - Phoenix, Arizona (USA)

BD PODIUM PRESENTATION

• "Advancing sa mRNA-LNP Vaccine Development: A Collaborative Approach to Drug-Device Combination Product Development"
• Learning objectives:
• Learn about the challenges in developing drug-device combinations, particularly with novel modalities like mRNA LNP vaccines in PFS.
• Discover the unique, iterative process designed for R&D decisions with early risk mapping, and PFS feature identification.
• Uncover the power of collaborative expertise in addressing vaccine stability challenges for successful delivery in PFS.
• Understand key elements in successful partnerships in early development.
• Speaker: Claire Brunet - R&D Staff Scientist at BD

BD TECH TALK

• "Flow Beyond Limits: BD Neopak™ XtraFlow™ Glass Prefillable Syringe System"
• Speaker: Maelle Douaire, R&D segment leader at BD

SCIENTIFIC POSTERS

• Poster 1 : How the use of artificial intelligence in Research and development helps drive innovation in drug combination products - Presenter: Diana Koschel, R&D Senior Manager at BD
• Poster 2: Application of Modeling as a Tool for Early Derisking of Parenteral Delivery, from the Primary Container to the Tissue - Presenter: Ludovic Gil, Senior R&D Engineer, at BD
• Poster 3: De-risking your drug-device combination product Abbreviated New Drug Application submission: A case study on leveraging formative human factors data generated by a device constituent developer - Presenter: Chloe Stoll, Senior Specialist Medical Affairs at BD